
Eric K. Nicholson
Examiner (ID: 1800)
| Most Active Art Unit | 3501 |
| Art Unit(s) | 3508, 3642, 2899, 3744, 3501, 3627, 3629, 3626, PQT, 3679 |
| Total Applications | 2110 |
| Issued Applications | 1732 |
| Pending Applications | 114 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8690160
[patent_doc_number] => 08389689
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-05
[patent_title] => 'Anti-GLP-1R antibodies and their uses'
[patent_app_type] => utility
[patent_app_number] => 12/913406
[patent_app_country] => US
[patent_app_date] => 2010-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6964
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12913406
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/913406 | Anti-GLP-1R antibodies and their uses | Oct 26, 2010 | Issued |
Array
(
[id] => 5952372
[patent_doc_number] => 20110033464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'IMMUNOGLOBULIN FUSION PROTEIN FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/910146
[patent_app_country] => US
[patent_app_date] => 2010-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9376
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033464.pdf
[firstpage_image] =>[orig_patent_app_number] => 12910146
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/910146 | IMMUNOGLOBULIN FUSION PROTEIN FORMULATIONS | Oct 21, 2010 | Abandoned |
Array
(
[id] => 5944200
[patent_doc_number] => 20110104820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'Tyrosine, Serine, And Threonine Phosphorylation Sites'
[patent_app_type] => utility
[patent_app_number] => 12/902261
[patent_app_country] => US
[patent_app_date] => 2010-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 27790
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104820.pdf
[firstpage_image] =>[orig_patent_app_number] => 12902261
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/902261 | Tyrosine, Serine, And Threonine Phosphorylation Sites | Oct 11, 2010 | Abandoned |
Array
(
[id] => 6149782
[patent_doc_number] => 20110021377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'USE OF A TRPC CHANNEL FOR THE TREATMENT OF A CARDIOVASCULAR DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/897892
[patent_app_country] => US
[patent_app_date] => 2010-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5974
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021377.pdf
[firstpage_image] =>[orig_patent_app_number] => 12897892
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/897892 | Treating cardiovascular disease with TRPC3 channel protein | Oct 4, 2010 | Issued |
Array
(
[id] => 5992544
[patent_doc_number] => 20110014197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'METHODS OF TREATING PRE-ECLAMPSIA OR ECLAMPSIA'
[patent_app_type] => utility
[patent_app_number] => 12/892652
[patent_app_country] => US
[patent_app_date] => 2010-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 30487
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20110014197.pdf
[firstpage_image] =>[orig_patent_app_number] => 12892652
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/892652 | METHODS OF TREATING PRE-ECLAMPSIA OR ECLAMPSIA | Sep 27, 2010 | Abandoned |
Array
(
[id] => 5977714
[patent_doc_number] => 20110071089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'PEPTIDE COMPOSITION FOR CANCER TREATMENT BY INHIBITING TRPV6 CALCIUM CHANNEL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/886397
[patent_app_country] => US
[patent_app_date] => 2010-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21651
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071089.pdf
[firstpage_image] =>[orig_patent_app_number] => 12886397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/886397 | Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity | Sep 19, 2010 | Issued |
Array
(
[id] => 8385955
[patent_doc_number] => 08263349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-11
[patent_title] => 'Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/804664
[patent_app_country] => US
[patent_app_date] => 2010-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 14575
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12804664
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/804664 | Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof | Jul 26, 2010 | Issued |
Array
(
[id] => 8183969
[patent_doc_number] => 20120114595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'SUGAR CHAIN-ADDED AILIM EXTRACELLULAR DOMAIN AND METHOD FOR PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/383845
[patent_app_country] => US
[patent_app_date] => 2010-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18336
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20120114595.pdf
[firstpage_image] =>[orig_patent_app_number] => 13383845
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/383845 | SUGAR CHAIN-ADDED AILIM EXTRACELLULAR DOMAIN AND METHOD FOR PRODUCING SAME | Jul 11, 2010 | Abandoned |
Array
(
[id] => 6439411
[patent_doc_number] => 20100279331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'Novel Transporter Protein in Mammal and Utilization of the Same'
[patent_app_type] => utility
[patent_app_number] => 12/817576
[patent_app_country] => US
[patent_app_date] => 2010-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 21363
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20100279331.pdf
[firstpage_image] =>[orig_patent_app_number] => 12817576
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/817576 | Transporter protein in mammal and utilization of the same | Jun 16, 2010 | Issued |
Array
(
[id] => 10062294
[patent_doc_number] => 09101117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-11
[patent_title] => 'SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto'
[patent_app_type] => utility
[patent_app_number] => 13/377277
[patent_app_country] => US
[patent_app_date] => 2010-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 26
[patent_no_of_words] => 36040
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377277
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/377277 | SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto | Jun 9, 2010 | Issued |
Array
(
[id] => 8201078
[patent_doc_number] => 08188081
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-29
[patent_title] => 'Methods of treating inflammation using prokineticin 1 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/797266
[patent_app_country] => US
[patent_app_date] => 2010-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 35
[patent_no_of_words] => 33529
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/188/08188081.pdf
[firstpage_image] =>[orig_patent_app_number] => 12797266
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/797266 | Methods of treating inflammation using prokineticin 1 receptor antagonists | Jun 8, 2010 | Issued |
Array
(
[id] => 6542145
[patent_doc_number] => 20100287672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'PLANT CELL SIGNALING GENES'
[patent_app_type] => utility
[patent_app_number] => 12/786876
[patent_app_country] => US
[patent_app_date] => 2010-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 215
[patent_figures_cnt] => 215
[patent_no_of_words] => 52160
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20100287672.pdf
[firstpage_image] =>[orig_patent_app_number] => 12786876
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/786876 | Plant cell signaling genes | May 24, 2010 | Issued |
Array
(
[id] => 6185001
[patent_doc_number] => 20110123986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS'
[patent_app_type] => utility
[patent_app_number] => 12/778010
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 78217
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 41
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20110123986.pdf
[firstpage_image] =>[orig_patent_app_number] => 12778010
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/778010 | METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS | May 10, 2010 | Abandoned |
Array
(
[id] => 6235348
[patent_doc_number] => 20100267052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES'
[patent_app_type] => utility
[patent_app_number] => 12/776601
[patent_app_country] => US
[patent_app_date] => 2010-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 59645
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267052.pdf
[firstpage_image] =>[orig_patent_app_number] => 12776601
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/776601 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES | May 9, 2010 | Abandoned |
Array
(
[id] => 6326889
[patent_doc_number] => 20100197596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Compositions and methods for diagnosis and treatment of type 2 diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/759072
[patent_app_country] => US
[patent_app_date] => 2010-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 47299
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197596.pdf
[firstpage_image] =>[orig_patent_app_number] => 12759072
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/759072 | Methods for treatment of type 2 diabetes | Apr 12, 2010 | Issued |
Array
(
[id] => 6339994
[patent_doc_number] => 20100247536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR ANTIBODIES FOR DIAGNOSTIC AND CLINICAL APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/732880
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14692
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247536.pdf
[firstpage_image] =>[orig_patent_app_number] => 12732880
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/732880 | Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications | Mar 25, 2010 | Issued |
Array
(
[id] => 7696192
[patent_doc_number] => 20110230398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'Apolipoprotein C-II or its active fractions for the prevention or treatment of obesity and related metabolic disorders'
[patent_app_type] => utility
[patent_app_number] => 12/727339
[patent_app_country] => US
[patent_app_date] => 2010-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1911
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230398.pdf
[firstpage_image] =>[orig_patent_app_number] => 12727339
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/727339 | Apolipoprotein C-II or its active fractions for the prevention or treatment of obesity and related metabolic disorders | Mar 18, 2010 | Abandoned |
Array
(
[id] => 8197059
[patent_doc_number] => 20120121591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3'
[patent_app_type] => utility
[patent_app_number] => 13/258454
[patent_app_country] => US
[patent_app_date] => 2010-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 81
[patent_figures_cnt] => 81
[patent_no_of_words] => 92236
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20120121591.pdf
[firstpage_image] =>[orig_patent_app_number] => 13258454
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/258454 | SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 | Mar 18, 2010 | Abandoned |
Array
(
[id] => 6622687
[patent_doc_number] => 20100311077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Use of GPR100 Receptor in Diabetes and Obesity Regulation'
[patent_app_type] => utility
[patent_app_number] => 12/725415
[patent_app_country] => US
[patent_app_date] => 2010-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 31226
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311077.pdf
[firstpage_image] =>[orig_patent_app_number] => 12725415
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/725415 | Use of GPR100 Receptor in Diabetes and Obesity Regulation | Mar 15, 2010 | Abandoned |
Array
(
[id] => 6188686
[patent_doc_number] => 20110171627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'ZCYTOR19 HETERODIMERIC CYTOKINE RECEPTOR POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/723364
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48532
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171627.pdf
[firstpage_image] =>[orig_patent_app_number] => 12723364
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/723364 | ZCYTOR19 HETERODIMERIC CYTOKINE RECEPTOR POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS | Mar 11, 2010 | Abandoned |